Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

626 Press Releases
DateTitleCompany
26 Mar 13 Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology Shire ,
Published by
Shire
26 Mar 13 SAFEWARE QUASAR EXHIBITS AT CHEMSPEC EUROPE Safeware Quasar
26 Mar 13 Lundbeck and Otsuka further expand their alliance and enter into collaboration for the development and commercialization of Lu AE58054 in development for Alzheimer’s disease H. Lundbeck A/S ,
Published by
Lundbeck
26 Mar 13 Sixth Consecutive "Best CRO" Award Nomination for Accelovance ACCELOVANCE,
Published by
PR Newswire
26 Mar 13 Recipharm site in France approved for supply of manufactured products to Japan Recipharm AB,
Published by
DeFacto
25 Mar 13 Results of St. Jude Medical’s RESPECT Trial Published in The New England Journal of Medicine St. Jude Medical, Inc,
Published by
Chandler Chicco Agency
25 Mar 13 Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind VANDA PHARMACEUTICALS INC,
Published by
PR Newswire
25 Mar 13 A new look for the Cetraben range of products for the treatment of dry skin and eczema Genus Pharmaceuticals ,
Published by
Packer Forbes Communications
25 Mar 13 Luke Johnson, leading entrepreneur, takes the helm at The Institute of Cancer Research The Institute of Cancer Research
22 Mar 13 MELBOURN SCIENTIFIC OPENS EU MARKET WITH INHALER TEST SERVICE Melbourn Scientific,
Published by
Holdsworth Associates
22 Mar 13 ClinTec chosen for insight into global networking techniques in the world of international business ClinTec International,
Published by
DeFacto
22 Mar 13 EUROPEAN CHMP ADOPTS POSITIVE OPINION FOR STRIBILD®, A ONCE-DAILY, INTEGRASE INHIBITOR-BASED, SINGLE TABLET REGIMEN FOR THE TREATMENT OF HIV-1 INFECTION Gilead Sciences
22 Mar 13 Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. Valeant Pharmaceuticals International, Inc
21 Mar 13 Managed Health Care Associates, Inc. (MHA) Announced Erik Halstrom, Vice President of MHA Specialty Pharmacy Solutions, Will Serve on the National Association of Specialty Pharmacy (NASP) Board of Directors MANAGED HEALTHCARE ASSOCIATES,
Published by
PR Newswire
21 Mar 13 ePharmaSolutions and CenterWatch Partner to Improve Patient Eligibility and Access to Clinical Trials EPHARMASOLUTIONS INC.,
Published by
PR Newswire
21 Mar 13 Almac’s Clinical Trial Workshop Series to Return in 2013 Almac Group,
Published by
DeFacto
21 Mar 13 Boehringer-Ingelheim, Roche, Novartis to discuss regulatory challenges occurring in emerging markets for Supply Chain at SMi’s Clinical Trial Logistics SMi Group
20 Mar 13 REAL WORLD STUDY COMPARING COMMONLY PRESCRIBED COPD MEDICINES SHOWS CHOICE OF TREATMENT HAS IMPACT ON PATIENT OUTCOMES AstraZeneca
15 Mar 13 Close the Gap Between EMA Policies and Clinical Trial Design SMi
14 Mar 13 Lilly Launches Latest Innovation in Insulin Delivery Lilly
14 Mar 13 Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference REDINGTON INC.,
Published by
PR Newswire
14 Mar 13 New treatment for advanced HER2+ breast cancer patients as Perjeta® (pertuzumab) gets regulatory green light Roche
14 Mar 13 Government prepares to act to attract drug research projects back to the UK, says Withers & Rogers Withers & Rogers ,
Published by
smarts
14 Mar 13 European Commission approves new pre-treatment options for QUTENZAT (8% capsaicin patch) in peripheral neuropathic pain Astellas Pharma Europe Ltd.,
Published by
Pegasus
13 Mar 13 iPLATO mobile health services reaches 5 million patients in the UK iPLATO Healthcare
13 Mar 13 Global food industry leaders say continual innovation is urgently needed to reduce pressures on price and food supply CropWorld Global 2013 ,
Published by
De Facto Communications
11 Mar 13 Chiltern Wins CRO Leadership Award From Life Science Leader CHILTERN INTERNATIONAL INC.,
Published by
PR Newswire
11 Mar 13 First Patient Enrolled in Third Phase III Study of Oral Laquinimod for Relapsing-Remitting Multiple Sclerosis TEVA,
Published by
Teva
11 Mar 13 Results from HPS2-THRIVE Study of TREDAPTIVE™ (extended-release niacin/laropiprant) Presented at American College of Cardiology Scientific Sessions Merck
11 Mar 13 Pharmaco-invasive strategy including Metalyse® delivers comparable clinical outcomes to primary PCI for STEMI patients who could not undergo primary PCI within one hour from first medical contact Boehringer Ingelheim
Advertising